Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Desentum reports positive findings for the First-in-Human clinical study of lead product candidate in birch pollen allergic adults

Desentum Oy, a clinical-stage biopharmaceutical company developing novel immuno­therapies for treating allergies, today announced positive First-in-Human clinical data of DM-101, its lead candidate for treatment of birch pollen allergy. DM-101 was found to be safe and well tolerated in a dose regimen of 5 ascending doses, and immunological marker results indicated a favourable immunological response.“We are very happy to have completed the clinical study despite the challenges posed by the Covid-19 pandemic. The preclinical models available for testing allergen immunotherapy products are

Skanska invests about SEK 450M in a new residential development project in Stockholm, Sweden

Skanska invests about SEK 450M in a new residential block with a total of 107 Nordic Swan ecolabelled apartments in Bromma, Stockholm, Sweden.The condominium project in Mariehäll consists of a total of three buildings. Water views and the proximity to Bällstaviken have been central to the design of both buildings, apartments, and courtyards. The courtyards, with a strong focus on greenery, offer natural meeting places for increased well-being in the area. The project is certified according to the Nordic Swan ecolabel, which means high demands on quality, environmental, energy and health

FY 2022 Q1 - Growth of 110% - full recovery in the market

SUMMARY FOR FINANCIAL YEAR 2022 Q1 Financial Highlights · Net sales in Q1 were SEK 21.2m, corresponding to a 110% increase compared with the same period in 2020 (SEK 10.1m). · Recurring revenues increased by 26%. Underlying organic sales growth on a proforma basis of 3.4%. · Normalised EBITDA (EBITDA before non-recurring items and FX translation) was SEK 0.9m compared to the same period in 2020 (SEK 2.4m). As we indicated at the beginning of the year, the company is investing for future growth which has led to the decrease in Normalised EBITDA. · EBITDA of SEK 0.0m

Report for the third quarter 2021: Another record quarter

The third quarter · Revenue was SEK 25,220 (14,481) million · EBITDA was SEK 6,582 (-66) million · Operating profit was SEK 5,800 (-973) million · Earnings per share were SEK 4.35 (-0.72)Comments by the CEO – continued strong earnings trend SSAB reports a continued strong earnings trend for Q3 2021. High steel prices in combination with a strong and stable internal performance saw us exceed the record in Q2, despite planned maintenance outages. During the quarter, SSAB made the world’s first fossil-free steel and delivered it to Volvo Group. We also signed a number of new

Invitation to presentation of Embellence Group’s interim report for the third quarter 2021

Embellence Group publishes the quarterly report for the third quarter (July to September) on October 25 at 08:00 CEST. In connection with the announcement, Embellence Group invites to a video conference on the same day, held at 10:00 CEST.The presentation will be held in English by Olle Svensk (CEO) and Pär Ihrskog (CFO). To attend, use the link  https://tv.streamfabriken.com/embellence-group-q3-2021 or dial in at SE: +46856642693 UK: +443333009274 US: +16467224903 Subscribe to reports and press releases:https://www.embellencegroup.com/newsroom/subscribe

Increased consumption of whole grains could significantly reduce the economic impact of type 2 diabetes

Increased consumption of whole grain foods could significantly reduce the incidence of type 2 diabetes and the costs associated with its treatment in Finland, according to a recent study by the University of Eastern Finland and the Finnish Institute for Health and Welfare. The findings were published in Nutrients.“Our study shows that already one serving of full grains as part of the daily diet reduces the incidence of type 2 diabetes at the population level and, consequently, the direct diabetes-related costs, when compared to people who do not eat whole grain foods on a daily basis. Over

Expansion of wind and solar power too slow to stop climate change

The production of renewable energy is increasing every year. But after analysing the growth rates of wind and solar power in 60 countries, researchers at Chalmers University of Technology and Lund University in Sweden and Central European University in Vienna, Austria, conclude that virtually no country is moving sufficiently fast to avoid global warming of 1.5°C or even 2°C. “This is the first time that the maximum growth rate in individual countries has been accurately measured, and it shows the enormous scale of the challenge of replacing traditional energy sources with

Axel Johnson International signs sustainability-linked loan with Swedish Export Credit Corporation (SEK)

Axel Johnson International increases its ambitions in sustainability and signs a sustainability-linked loan of 55 million euro with Swedish Export Credit Corporation (SEK). The loan is linked to several sustainability-related goals with focus on energy efficiency and renewable energy.“Thanks to many years of structured sustainability work and increased ambitions in our new group-wide sustainability strategy, we have been able to agree on this loan with SEK. It’s very exciting to connect our efforts in sustainability to financing in this manner,” says Malin Ripa, Head of Sustainability, Axel

Agnafit Bidco extends the acceptance period for the public offer to the shareholders of Sobi and announces its intention not to increase the price of SEK 235 per share in the Offer

This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important information" at the end of this announcement and in

Realfiction Holding AB announces its Q3 Interim Report for July – September 2021

The company announces that the Q3 Interim Report for July – September 2021 is now available. The full report is attached as a separate document and can also be downloaded from the company’s website (www.realfiction.com). A printed copy can be ordered via investor@realfiction.com. Below is a brief summary of the Q3 Interim Report.Important key figures:• 329% increase in total revenue Q3, 2021 compared to Q3, 2020• 332% increase in gross profit in Q3, 2021 compared to Q3, 2020• Slightly increased gross profit margin of 55.9% in Q3, 2021 compared to 55.5% in Q3, 2020• Cash-based net

Aker Carbon Capture ASA: third-quarter results 2021

Aker Carbon Capture made good progress with new and existing projects in the third quarter, as the pure-play carbon capture specialist continued its international expansion."We see clear signs of acceleration across the carbon capture market worldwide, and we continue to position our company to be a leading player in this important and fast-growing industry," said Valborg Lundegaard, Chief Executive Officer of Aker Carbon Capture. Highlights in the third quarter included progress made in the Brevik CCS project and securing a number of agreements with new customers in the company's

Ratos AB: Improved earnings in the companies, strong order intake and new acquisitions

Q3 2021Performance Ratos Group · Adjusted[1)] operating profit from continuing operations amounted to SEK 356m (318) · Adjusted[1)] profit for the period amounted to SEK 208m (119) · Profit for the period was impacted by an unrealized loss of SEK 149m related to the revaluation of shares in Dun & Bradstreet Holding Inc. · Operating profit from continuing operations amounted to SEK 208m (318) · Profit for the period amounted to SEK 60m (119) · Diluted earnings per share amounted to SEK 0.04 (0.31) Performance Ratos business group, adjusted for Ratos’s holdings ·

Krista Audere from Latvia wins prestigious Eric Ericson Award

At the final concert of the Eric Ericson Award competition in the Swedish Radio Concert Hall Berwaldhallen in Stockholm, the latvian conductor Krista Audere was elected winner of the competition, by an international jury. Harry Bradford from Great Britain and Julia Selina Blank from Germany also participated in the final. Concerts with ten European radio choirs and a prize sum of 100 000 Swedish kronor (10.000 Euros) awaits the winner. Krista Audere, winner of the Eric Ericson Award 2021. Photo: Bo Söderström The Jury’s citation reads: “With outstanding energy and a dynamic poetic

Nordea Bank Abp: Repurchase of own shares on 22.10.2021

Nordea Bank AbpStock exchange release – Changes in company’s own shares22.10.2021 at 22.30 EET   Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 22.10.2021 completed repurchases of own shares (ISIN: FI4000297767) as follows:   Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR*Code) **XHEL 306,810 11.03 3,383,040.47CEUX 315,130 11.03 3,475,888.83AQEU 67,881 11.06 750,493.10TQEX 310 11.12

Scandinavian ChemoTech's COO completes his assignment

Scandinavian ChemoTech's COO Urban Widen ends his interim assignment after a job well done.On a consulting basis, Urban Widén has been linked to Scandinavian ChemoTech as COO to help build a new expansive strategy. This assignment has now come to a successful end.   “Urban has, with his long experience from the industry, been an important asset in the Company's work towards a new strategy and his insights has been essential for the Company's new path choice. I want to thank Urban for a strong effort and wish him luck in his continued career. "- says Mohan Frick, CEO and co-founder of

Nel ASA: Exercise of employee share options and issue of shares

(Oslo, 22 October 2021) Nel ASA (the Company) today has resolved, in accordance with the authorization granted by the general meeting on 15 April 2021, to issue 200,800 new shares to fulfil the Company's obligations in the groupwide share option program comprising all employees in Nel fulfilling certain criteria, specified in the Company's annual report (note 6), thereby increasing the Company's share capital by NOK 40,160. In total 10 employees in the group exercised 200,800 options, where 35,000 options were exercised at the strike price of NOK 3.24, and 165,800 options were exercised at

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 22.10.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 22.10.2021 at 18:30 EEST ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 22.10.2021 Date 22.10.2021Exchange transaction BuyShare class ALEXAmount 339Average price/share 8.3000 EURHighest price/share 8.3000 EURLowest price/share 8.3000 EURTotal price 2,813.70 EUR The shares held by Alexandria Pankkiiriliike Oyj on 22.10.2021: ALEX 33,974 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 22.10.2021

United Bankers Corporation NOTIFICATION 22.10.2021 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 22.10.2021 Date 22.10.2021Exchange transaction BuyShare class UNITEDAmount 3Average price/share 13.8000 EURHighest price/share 13.8000 EURLowest price/share 13.8000 EURTotal price 41.40 EUR The shares held by United Bankers Corporation on 22.10.2021: UNITED 50,590 On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka

DNB Markets - Nexam Chemical: Q3 is history, opportunities ahead

Q3 sales missed our forecast by 13%, driven mainly by vacation effects but also the general raw-material shortage globally, which may have pushed some sales into Q4e. However, this has not changed our view of Nexam Chemical, and we still believe the 2022 sales target of SEK275m–325m is within reach with its current platforms. Following the Q3 results and a change of analyst, we have lowered our estimates slightly but reiterate our fair value of SEK15–20. We estimate a strong end to 2021 and consider the company well-positioned to continue executing on its profitable growth journey. Additional

#21-349 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-348 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

RaySearch and Mevion to develop next-generation treatment planning techniques for FLASH proton radiotherapy treatment

RaySearch Laboratories AB (publ) and Mevion Medical Systems, two companies that are leading the field of proton therapy, announce a collaboration to develop advanced treatment planning techniques for FLASH* delivery with the MEVION S250i Proton Therapy System.The collaboration will explore FLASH intensity modulated proton therapy (IMPT) delivery using a technique that supports the delivery of large-volume clinical FLASH fields through the combination of smaller fields, each delivered at FLASH dose rates which complements Mevion’s advanced HYPERSCAN delivery system.  Townsend Zwart, Vice

Stabilisation Notice

Goldman Sachs Bank Europe SE ("Goldman Sachs") has, in its capacity as Joint Global Coordinator and Stabilization Manager, notified Truecaller AB (publ) ("Truecaller" or the "Company") that stabilization measures have been undertaken in the Company's class B shares traded on Nasdaq Stockholm.NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, FULLY OR PARTLY, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER

Profit warning: Apetit revises its estimate of operating profit for 2021 and provides preliminary information for the period January - September 2021

Apetit Plc, Inside information, 22 October 2021 at 17:35 p.m.Profit warning: Apetit revises its estimate of operating profit for 2021 and provides preliminary information for the period January - September 2021 Apetit Plc revises its estimate of operating profit for 2021. The company estimates that the operating profit from continuing operations will be below year 2020 level (EUR 3.9 million in 2020). Record-high freight costs and unfavorable sales commitments in relation to the grain harvest quality will weaken Grain Trade's profit outlook for the last quarter of the year. The profit

There are no items matching the current filter
There are no more items matching the current filter
Back to top